INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 2558
FORMATION PROCESSES AND MORPHOLOGICAL CHARACTERISTICS OF
CONCOMITANT OCCURRENCE OF MALIGNANT NEOPLASMS AND
PULMONARY TUBERCULOSIS
Iskandarovа Iroda Mashrabjon kizi
Bukhara State Medical Institute, Republic of Uzbekistan, Bukhara
Annotation:
This article discusses the formation processes and morphological features of the
simultaneous presence of malignant tumors and pulmonary tuberculosis. The paper examines
the mechanisms that contribute to the development of these diseases in their combined presence,
as well as describes the characteristic morphological changes in tissues. The analysis provides a
deeper understanding of the interaction between malignant neoplasms and pulmonary
tuberculosis, which can contribute to the development of more effective methods of diagnosis
and treatment.
Keywords:
malignant tumors, pulmonary tuberculosis,
morphological features, mechanisms
of development, concomitant diseases, diagnosis, treatment.
Relevance
The study of the pathogenesis and morphological features of the combination of
malignant neoplasms and pulmonary tuberculosis is extremely relevant in the modern medical
context. Both of these diseases occupy a significant place in the structure of morbidity and
mortality, and their combined course is a complex clinical problem.
Malignant lung tumors are one of the leading causes of cancer-related deaths worldwide.
According to the World Health Organization, lung cancer is the leading cause of cancer death,
making it a critical medical research target. On the other hand, tuberculosis, despite significant
advances in its diagnosis and treatment, remains a serious infectious disease, especially in
developing countries. In 2022, tuberculosis was included in the list of priority infectious diseases
that require increased attention and resources.
The combined course of malignant neoplasms and pulmonary tuberculosis significantly
complicates the diagnosis and treatment of both diseases. Tuberculosis can mask the symptoms of
malignant tumors, making it difficult to detect them in a timely manner. At the same time, the
presence of a malignant tumor can weaken the immune system, which increases the risk of
reactivation of latent tuberculosis or the development of a new infection. This creates additional
difficulties for clinicians in choosing the best treatment strategies and patient management.
In addition, the interaction of pathogenetic mechanisms of these diseases can lead to
unique morphological changes that need to be taken into account when developing diagnostic
and therapeutic approaches. Tuberculosis granulomas can create favorable conditions for the
growth and metastasis of malignant cells, which requires a detailed study and understanding of
these processes. It is also important to take into account that the combination of these diseases
can lead to a change in the clinical picture, which complicates the diagnosis and management of
patients.
In modern medical practice, cases of combined pathology are increasingly occurring,
especially in conditions of immunosuppressioncaused by cancer treatment or other factors. This
requires the development of new, more effective and personalized approaches to diagnosis and
treatment, which will take into account the features of the combined course of malignant
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 2559
neoplasms and pulmonary tuberculosis.
Thus, the study of the pathogenesis and morphological features of the combination of
these diseases is a necessary step to improve the quality of medical care and increase patient
survival. The results obtained will contribute to the development of more accurate diagnostic
methods that allow timely detection and differentiation of pathological changes, as well as the
development of new therapeutic strategies aimed at effective management of these complex
clinical cases.
Goal
The aim of this study is to study the pathogenesis and morphological features of the
combination of malignant neoplasms and pulmonary tuberculosis, as well as to identify the
relationships between these diseases in order to develop more effective methods of diagnosis and
treatment.
Materials and methods
The study used materials from 100 patients who were diagnosed with both malignant
neoplasms and pulmonary tuberculosis. The
study included histological and
immunohistochemical examination of biopsy material, as well as analysis of clinical data of
patients. Histological analysis included staining of tissue sections according to standard methods,
which revealed morphological changes characteristic of both diseases. An immunohistochemical
study was used to determine the expression of markers associated with tuberculosis and
malignant tumors. Statistical data processing was performed using the SPSS program, which
allowed us to identify correlations between various pathogenetic and morphological indicators.
Results
The results of the study showed that the combination of malignant neoplasms and
pulmonary tuberculosis leads to significant morphological changes in lung tissues. In particular, it
was found that the presence of tuberculosis granulomas promotes accelerated growth of
malignant cells and increases their aggressiveness. An immunohistochemical study showed
increased expression of markers of inflammation and cell proliferation in the affected tissues.
Statistical analysis of the data showed significant correlations between the severity of
tuberculosis and the stage of development of a malignant tumor, which confirms the mutual
influence of these diseases. The results obtained can serve as a basis for the development of new
diagnostic and therapeutic approaches aimed at improving the treatment outcomes of patients
with comorbidity.
Conclusion
The conclusion of the study emphasizes the importance of studying the pathogenesis and
morphological features of the combination of malignant neoplasms and pulmonary tuberculosis.
The data obtained confirm the mutual influence of these diseases and their ability to enhance each
other's pathological processes. The results of histological and immunohistochemical analysis
indicate the need to develop comprehensive approaches to the diagnosis and treatment of
patients with this combined pathology. An important aspect is early detection and a differentiated
approach to treatment, which can significantly improve the prognosis and quality of life of
patients. Further research in this area should focus on developing more specific markers and
therapeutic strategies that will effectively control both diseases.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 2560
Literature:
1. A. Sadovnikov, K. I. Panchenko. Infiltrative tuberculosis and lung cancer/ Problems of
tuberculosis and lung diseases. - 1-2007. - p. 55-60.
2. V. Vencevicius, S. Tsitsenas, R. Tikuisis. Possibilities of surgical treatment in combination
of tuberculosis and lung cancer. / Problems of tuberculosis and lung diseases- 5 - 2007 - P.
32-36.
3. S. Zinoviev, V. L. Kovalenko. Questions of morphology and pathogenesis of primary lung
cancer in combination with pulmonary forms of tuberculosis. / Scientific works of the
Omsk Medical Institute. - 1971g. - 103-P. 101-106. 4. A. A. Sadovnikov, K. I. Panchenko.
The relationship between the tumor and tuberculosis process in the lung./ Thoracic and
cardiovascular surgery-4-1995 p. 51-56.
4. Dacosta NA, Krinare SG. Association of lung carcinoma and tuberculosis // J Postgrad
Med. – 1991. - №37(4). – Р.185-189.
5. Darvin P., Toor S.M., Sasidharan V. N., E. Elkord, Immune checkpoint inhibitors: recent
progress and potential biomarkers, Exp. // Mol. Med. – 2018. - №50. – Р.165.
6. Delaunay M., Cadranel J., Lusque A., Meyer N., Gounant V., Moro-Sibilot D., et al.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients //
Eur. Respir. J. – 2017. - №50. – Р.1700050.
7. Dobler C. C. Cumulative incidence and incidence rate ratio for estimation of risk of
tuberculosis in patients with cancer // Clin. Infect. Dis. – 2017. – Vol. 65, № 8. – P. 1423-
1424.
8. Dobler C.C. Biologic agents and tuberculosis // Microbiol Spectr. – 2016. - №4.- Р.1128
9. Dobler C.C. Biological agents and tuberculosis: risk estimates and screening strategies //
Int J Rheum Dis. – 2015. - №18. – Р.264–267.
10. Dobler C.C., Cheung K., Nguyen J. et al. Risk of tuberculosis in patients with solid cancers
and haematological malignancies: a systematic review and meta-analysis // Eur Respir J. –
2017. - №50. – Р.1700157.
